Join C2E2 for a spotlight session featuring Dr. Gillian Hanley.
Ovarian cancer remains one of the most lethal gynecologic malignancies, largely due to the absence of effective screening strategies and the frequent diagnosis at advanced stages. Increasing evidence that many high-grade serous ovarian cancers originate in the fallopian tube has created new opportunities for prevention. Surgical procedures such as hysterectomy or tubal permanent contraception provide opportunities to remove the fallopian tubes through opportunistic salpingectomy. However, more opportunities exist when we expand to general surgery, including gallbladder surgery, appendectomy and colorectal surgery. Embedding prevention within these common clinical interactions allows the health system to reach large populations without requiring additional infrastructure or major changes to care pathways.
This presentation will outline a population-based strategy for ovarian cancer prevention that leverages existing surgical and contraceptive care to meaningfully reduce future disease burden.